Squarepoint Ops »

Design Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2023-12-31 $102k 38k 2.65
2023-09-30 $100k 43k 2.36
2023-06-30 $262k 42k 6.30
2023-03-31 $630k 109k 5.77
2021-03-31 $702k 24k 29.88

More positions owned by Squarepoint Ops

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Msci Eafe Etf Put Option (EFA)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Pdd Holdings Sponsored Ads (PDD)
Amazon Call Option (AMZN)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Advanced Micro Devices Call Option (AMD)
Royal Caribbean Cruises (RCL)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Squarepoint Ops

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Citadel Advisors
Baker Bros. Advisors
Tang Capital Management
Almitas Capital
Goldman Sachs Group
Vanguard Group
BML Capital Management
Two Sigma Advisers
Jacobs Levy Equity Management
Two Sigma Investments
Millennium Management
Walleye Trading Advisors
Assenagon Asset Management

View all funds holding Design Therapeutics